The authors, however, caution against considering these results as general because they were obtained in predominantly male, young people, and members of the British armed forces
NSFC 82160484), Guizhou Province Science Plan Program [Qian Ke He Foundation-ZK (2022) general
Los estudios de citotoxicidad in vitro confirman la ausencia de toxicidad celular a concentraciones fisiolgicas y suprafisiolgicas
The REDEFINE 1 Phase 3 trial demonstrated 20.4% mean weight loss at 68 weeks in 3,417 participants, and Novo Nordisk has filed an NDA with the FDA
Transparency about the regulatory status of the treatment : A responsible doctor will clearly explain whether a proposed treatment is HSA-approved for its intended use, or whether it constitutes off-label use, and will document informed consent accordingly